Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CRA International
CRAI
$1.23B
| $250K | ﹤0.01% |
1,453
+328
| +29% | +$53.1K |
|
3627
Nordic American Tanker
NAT
$1.36B
| $250K | ﹤0.01% |
62,861
+9,444
| +18% | +$38K |
|
3628
Hyster-Yale Materials Handling
HY
$576M
| $250K | ﹤0.01% |
3,585
-7,515
| -68% | -$513K |
|
3629
Ibotta
IBTA
$618M
| $249K | ﹤0.01% |
+3,310
| New | +$308K |
|
|
EH
3630
EHang Holdings
EH
$375M
| $248K | ﹤0.01% |
+18,297
| New | +$309K |
|
3631
Enliven Therapeutics
ELVN
$3.78B
| $248K | ﹤0.01% |
10,602
+2,769
| +35% | +$58.3K |
|
|
BPT
3632
PUT
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $247K | ﹤0.01% |
100,000
| – | – |
|
3633
Fidelity MSCI Real Estate Index ETF
FREL
$1.53B
| $245K | ﹤0.01% |
9,650
+8,716
| +933% | +$217K |
|
3634
Hackett Group
HCKT
$281M
| $244K | ﹤0.01% |
11,225
+1,927
| +21% | +$42.7K |
|
|
IMVP
3635
Invesco India ETF
IMVP
$124M
| $243K | ﹤0.01% |
8,326
-399
| -5% | -$11K |
|
3636
BlueLinx
BXC
$430M
| $243K | ﹤0.01% |
2,614
+350
| +15% | +$37.1K |
|
3637
iShares Morningstar Mid-Cap ETF
IMCB
$1.65B
| $242K | ﹤0.01% |
3,455
-425
| -11% | -$30K |
|
3638
TeraWulf
WULF
$7.48B
| $242K | ﹤0.01% |
54,392
-117,322
| -68% | -$317K |
|
3639
Altimmune
ALT
$568M
| $242K | ﹤0.01% |
36,385
-706,528
| -95% | -$5.21M |
|
|
JMIA
3640
Jumia Technologies
JMIA
$708M
| $241K | ﹤0.01% |
34,383
-39,965
| -54% | -$246K |
|
3641
Diebold Nixdorf
DBD
$2.6B
| $240K | ﹤0.01% |
6,230
-86,258
| -93% | -$3.29M |
|
3642
Energy Fuels
UUUU
$2.68B
| $240K | ﹤0.01% |
39,551
+2,829
| +8% | +$17.3K |
|
3643
WisdomTree Floating Rate Treasury Fund
USFR
$18.1B
| $239K | ﹤0.01% |
4,758
-230
| -5% | -$11.6K |
|
3644
Phreesia
PHR
$689M
| $238K | ﹤0.01% |
11,204
+2,283
| +26% | +$49.5K |
|
|
ATSG
3645
DELISTED
Air Transport Services Group
ATSG
| $237K | ﹤0.01% |
17,090
+1,256
| +8% | +$16.6K |
|
|
DHC
3646
Diversified Healthcare Trust
DHC
$2.15B
| $237K | ﹤0.01% |
77,584
+7,626
| +11% | +$19.4K |
|
3647
Genco Shipping & Trading
GNK
$1.1B
| $236K | ﹤0.01% |
11,077
+2,009
| +22% | +$43.2K |
|
3648
Liberty Global Class A
LBTYA
$3.59B
| $236K | ﹤0.01% |
13,535
-130,234
| -91% | -$2.2M |
|
3649
Liquidia Corp
LQDA
$7.72B
| $235K | ﹤0.01% |
19,590
-4,800
| -20% | -$63.7K |
|
3650
AbCellera Biologics
ABCL
$1.65B
| $235K | ﹤0.01% |
79,289
+75,249
| +1,863% | +$285K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.